Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers
Open Access
- 19 November 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (11) , e111927
Abstract
Altered expression of Mcl-1, an anti-apoptotic member of the Bcl-2 family, has been linked to the progression and outcome of a variety of malignancies. We have previously reported the overexpression of Mcl-1 protein in human oral cancers. The present study aimed to evaluate the clinicopathological significance of the expression of three known Mcl-1 isoforms in oral tumors and the effect of targeting Mcl-1L isoform on chemosensitivity of oral cancer cells. The expression of Mcl-1 isoforms- Mcl-1L, Mcl-1S & Mcl-1ES was analyzed in 130 paired oral tumors and 9 oral cell lines using quantitative real-time PCR & protein by western blotting. The Mcl-1 mRNA levels were correlated with clinicopathological parameters and outcome of oral cancer patients. The effect of Mcl-1L shRNA or Obatoclax (a small molecule Mcl-1 inhibitor), in combination with Cisplatin on chemosensitivity of oral cancer cells was also assessed. Anti-apoptotic Mcl-1L was predominantly expressed, over low or undetectable pro-apoptotic Mcl-1S and Mcl-1ES isoforms. The Mcl-1L transcripts were significantly overexpressed in all cancer cell lines and in 64% oral tumors versus adjacent normals (P<0.02). In oral cancer patients, high Mcl-1L expression was significantly associated with node positivity (P = 0.021), advanced tumor size (P = 0.013) and poor overall survival (P = 0.002). Multivariate analysis indicated Mcl-1L to be an independent prognostic factor for oral cancers (P = 0.037). Mcl-1L shRNA knockdown or its inhibition by Obatoclax in combination with Cisplatin synergistically reduced viability and growth of oral cancer cells than either treatment alone. Our studies suggest that overexpression of Mcl-1L is associated with poor prognosis and chemoresistance in oral cancers. Mcl-1L is an independent prognostic factor and a potential therapeutic target in oral cancers.Keywords
This publication has 45 references indexed in Scilit:
- Challenges of the Oral Cancer Burden in IndiaJournal of Cancer Epidemiology, 2012
- Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cellsRadiation Oncology, 2012
- Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay - A comparative studyRadiation Oncology, 2012
- Targeting Mcl-1 for the therapy of cancerExpert Opinion on Investigational Drugs, 2011
- Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2011
- Nuclear localization of Nm23‐H1 in head and neck squamous cell carcinoma is associated with radiation resistanceCancer, 2010
- Mcl‐1; the molecular regulation of protein functionFEBS Letters, 2010
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Chromosomal imbalances in oral squamous cell carcinoma: Examination of 31 cell lines and review of the literatureOral Oncology, 2008
- Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosisProceedings of the National Academy of Sciences, 2007